(Re)thinking Drug Discovery

Delivering better cancer therapies

Metabolite characterisation to accelerate drug discovery

How come we landed on the moon within a decade, but still haven’t beaten cancer?

Cleaning out disease – PROTACs on the rise

The dose maketh the poison. Or the cure?

Towards an in vitro assay for fibrosis research

Do new cancer treatments mean cancer patients live longer?

The Rule of 5 – Two decades later

Designing Cancer Drugs – the Scientist vs Patient Perspective

Crossing the Great Divide; the shadowy issue of secondary brain cancers

Where’s my chemical?

Towards the Holy Grail of Computational Chemistry